In order to participate in a course you must be a member of Colgate Oral Health Network. Registration is completely free. Register now.

Appropriate Chemotherapeutics for Advanced Periodontal Therapies

Gregory E. Oxford DDS, MS, PhD

Not all patients that need or require surgical periodontal care are candidates for this form of therapy. A variety of factors preclude them from receiving or pursuing surgery to correct their problems. This population of patients may benefit from a variety of chemotherapeutic pharmacologic agents currently available to affect host modulation and address their disease. This program will explore the rationale and appropriate usage of pharmacologic agents used as adjuncts to traditional modes of periodontal therapy as well as DNA culturing to assist your selection of medications.

Participants will :    

  • recognize the etiology of periodontal disease
  • recognize the patients that can most benefit from adjunctive pharmaco-therapeutic medications
  • understand the methods to determine which medications may be most advantageous for  their patients
  • CategoriesPeriodontics
  • LanguageEnglish
  • Release dateWednesday 24th July, 2013, 12:00 AM
  • Expiration dateWednesday 24th July, 2019, 12:00 AM
  • AGD PACE subject code(s)490
“Appropriate Chemotherapeutics for Advanced Periodontal Therapies” is co-sponsored by Tribune Group GmbH. Tribune Group GmbH is a recognized ADA CERP and AGD PACE provider. At the end of the webinar, after passing the C.E. Quiz, you will be able to download your ADA CERP and AGD PACE C.E. Certificates.